Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Opens Direct-To-Consumer Amazon Store under Pure Mushrooms Brand

PULL subsidiary Pure Mushrooms Corp. opens direct-to-consumer e-Commerce store on Amazon platform Store features Reishi, Maitake formulations with plans to add Lion’s Mane in summer 2021 Global functional mushroom market valued at $25.4 billion in 2020, expected CAGR of 8.44% from 2021-2026 Company expands psychedelic vertical through letter of intent with Psyence Group to co-produce […]

Brain Scientific Inc. (BRSF) Poised to Solve Major Obstacles to Neurological Testing in Pediatric Patients

There is a significant need for EEG diagnostics in pediatric patients, but traditional testing is challenging due to poorly fitting adult-sized equipment, which also increases resistance to testing This leaves a considerable gap in neurological care for young patients BRSF’s Pediatric NeuroCap steps in to solve major barriers limiting EEG monitoring in pediatric care There […]

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Working to Make Blue Light Cystoscopy Easier to Use and More Accessible to Hospitals and Patients at a Lower Cost

Imagin Medical Inc. has designed a system to improve the visualization of bladder cancer during minimally invasive surgery that will display, simultaneously, white and blue light images side-by-side, to help surgeons more easily identify and locate cancerous tumors for removal The company’s i/Blue Imaging System(TM) has the potential to make bladder cancer detection and removal […]

Infobird Co., Ltd. (NASDAQ: IFBD) Extends Commitment to Ecological Cooperation with New Agreement with CESTC 

Infobird has always held that the growth of China’s intelligent customer service industry is contingent on ecological cooperation Recently, IFBD inked an ecological cooperation agreement with CESTC furthering its commitment to its long-held stance The agreement will help create a customer-centered, mutually beneficial, and symbiotic ecological system that is expected to grow and transform China’s […]

Healthtech Solutions Inc. (HLTT) Enters Precision Oncology Market with Acquisition of Varian Biopharmaceuticals

Ability to tailor diagnostics, therapeutics to specific patients is key to precision medicine Global precision oncology market projected to grow at CAGR of 9.9% over the next eight years, will reach $99.7 billion by 2027 Varian Bio making significant headway in development of two preclinical experimental cancer drugs Healthtech Solutions (OTC: HLTT) is making a strong […]

Asia Broadband Inc.’s (AABB) Strong Q1 2021 Balance Sheet Sets Foundation for Robust Performance, Fulfillment of Strategic Goal

Asia Broadband recently released Q1 2021 results featuring a strong balance sheet as indicated by over $100 million in total assets, an increase of 283% from a similar period last year The results signal AABB’s highly liquid position to fully fund and rapidly grow its gold mining and cryptocurrency operations AABB intends to acquire high-yield […]

SRAX Inc. (NASDAQ: SRAX) Subsidiary LD Micro to Collaborate with InvestorBrandNetwork on Upcoming Invitational XI Microcap Conference

IBN joining forces with LD Micro to promote Invitational XI Microcap Conference IBN amplifies brand awareness across 5,000+ strategic distribution partners, social media network includes 2+ million followers and engagements LD Micro portal provides exclusive intraday information covering stocks with $50-300 million market capitalizations Conference features 25-minute presentations by over 180 companies, keynote speakers and […]

 

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Strengthens Rare Disease Pipeline Program Through UK Regulatory Innovation Designation

March 20, 2026

Regulatory recognition from international health authorities can significantly shape the trajectory of emerging therapies worldwide, particularly in rare disease development where clinical pathways are often complex and resource intensive. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases and unmet medical needs, recently received such recognition as its […]

Rotate your device 90° to view site.